Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
33.3%
% of MEDX's 30 holdings also in PJP
33.3%
% of PJP's 30 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 9.6% | 5.2% | 5.2% |
|
JOHNSON & JOHNSON | 5.1% | 5.1% | 5.1% |
|
AMGEN INC | 6.3% | 5.0% | 5.0% |
|
ELI LILLY & CO | 16.8% | 4.7% | 4.7% |
|
PFIZER INC | 4.0% | 4.9% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PJP
|
ELI LILLY & CO | 12.1% |
 |
NOVARTIS AG-ADR | 6.6% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.6% |
|
ALNYLAM PHARMACEUTICALS INC | 4.7% |
 |
ALKERMES PLC | 4.7% |
|
ABBVIE INC | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 3.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.7% |
|
CRISPR THERAPEUTICS AG | 2.4% |
|
IONIS PHARMACEUTICALS, INC. | 2.4% |
MEDX Underweight Relative to PJP
|
GILEAD SCIENCES INC | -5.2% |
|
ABBOTT LABORATORIES | -5.0% |
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
BIOSANTE PHARMACEUTICALS INC | -3.5% |
|
PERRIGO CO | -3.1% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
INNOVIVA, INC. | -2.8% |
|
PACIRA PHARMACEUTICALS INC | -2.8% |
|
SUPERNUS PHARMACEUTICALS INC | -2.8% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.7% |